5 minute read
Aug. 26, 2022
SAGE-718: an Oral N-methyl-d-Aspartate Receptor (NMDAR) Positive Allosteric Modulator
SAGE-718
oral NMDAR positive allosteric modulator Ph. II candidate in neurology from previously disclosed PAM and opt J. Med. Chem., July 2, 2022 Sage Therapeutics, Inc., Cambridge, MA